scholarly journals Cost-effectiveness evaluation of linezolid, vancomycin and teicoplanin in treating nosocomial pneumonia caused by methicilin resistant staphylococcus aureus (mrsa) – Public health care system perspective

2013 ◽  
Vol 16 (3) ◽  
pp. A92-A93
Author(s):  
R.K. Fujii ◽  
P. Hájek ◽  
G.D.A Lanzara ◽  
D.F. Manfrin ◽  
J. Mould
Sign in / Sign up

Export Citation Format

Share Document